British Lab Develops Alcohol-Free Drinks Aiming to Mimic Alcohol’s Effects

A British laboratory is at the forefront of developing a novel category of beverages that aim to replicate the social and relaxing effects of alcohol, but without any alcohol content. This innovation could significantly alter the landscape of the rapidly growing non-alcoholic drink market.

The initiative is spearheaded by David Nutt, a neuroscientist with extensive experience in researching the effects of drugs on the brain, addiction, and anxiety. Nutt co-founded GABA Labs with the ambitious goal of offering social drinkers the desired effects of alcohol, such as euphoria and disinhibition, while eliminating the risks associated with traditional alcohol consumption, including addiction, health issues, and hangovers.

The core of this development lies in a patented molecule named Alcarelle. This compound is described as odorless, tasteless, and colorless, designed to enhance socialization and relaxation by amplifying the effects of gamma-aminobutiric acid (GABA), a neurotransmitter that signals the brain to relax. GABA Labs aims for Alcarelle to surpass traditional alcohol in its effects without being addictive.

Timeline and Current Progress

GABA Labs anticipates that Alcarelle and its derivative products will be available in the U.S. by 2028. However, David Nutt has expressed optimism for a commercial release as early as late 2027. Reports from January indicated that the company aimed to complete FDA trials within the current year to facilitate this timeline.

For nearly a decade, GABA Lab has been focused on identifying and refining molecules that interact with GABA receptors in the brain to achieve the desired effects while mitigating negative ones. The laboratory has reportedly narrowed down its options to three 'finalist' molecules and plans to advance the most promising candidate for further research and development. This work has already generated considerable anticipation.

Early Product Launches

GABA Labs has already introduced products designed to offer a preview of their objectives. In 2021, the company launched Sentia in the UK, followed by a U.S. release. While Sentia does not yet contain the Alcarelle molecule, it is formulated with natural ingredients intended to provide a functional alternative that enhances social connection for consumers seeking an experience beyond traditional alcohol or non-alcoholic options.

More recently, the team has focused on creating specific alcoholic-style beverages. In 2025, EFE reported on the launch of Gabyr, a non-alcoholic beer designed to induce a similar sense of disinhibition as traditional alcoholic drinks. According to the lab's co-founder, Gabyr offers relaxation and sociability with a significantly reduced impact compared to alcohol. The company is also reportedly developing a non-alcoholic whisky and wine.

Market Impact and Future Questions

The development holds significance due to its potential to tap into a lucrative and evolving market. The global alcohol industry has seen shifts, with younger generations showing less inclination towards alcohol and a growing interest in "sober curious" trends and non-alcoholic alternatives. Statista projects global sales of non-alcoholic beer to exceed $50 billion by 2028, highlighting substantial market growth.

However, the prospect of alcohol-free beverages that mimic intoxication raises several important questions. Regulatory bodies will need to consider how to approach such products, particularly concerning their impact on driving and the potential for misuse. The effectiveness of current methods for detecting alcohol impairment, like breathalyzers, would also need reevaluation. Experts like Professor Kenneth Sher of the University of Missouri have expressed skepticism about a purely GABA-based substitute for alcohol, while others, such as Jim Cook, have raised concerns about potential side effects like drowsiness or memory loss.

Datos clave
| Aspect | Detail |
|—|—|
| Company | GABA Labs |
| Key Molecule | Alcarelle |
| Lead Scientist | David Nutt |
| Target Launch (US) | 2028 (optimistic: late 2027) |
| Initial Products | Sentia, Gabyr (non-alcoholic beer) |

This innovation could offer a new avenue for social drinkers seeking the convivial aspects of alcohol without the associated health and social risks. As the non-alcoholic beverage market continues its upward trajectory, products like those developed by GABA Labs may play a pivotal role in shaping future consumer choices.

Fuente: Xataka, https://www.xataka.com/magnet/cerveza-negocio-grande-que-ha-activado-nueva-carrera-cerveza-alcohol-capaz-emborrachar-1

Datos clave